The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...

In a landmark study published in Nature, scientists from the Ifakara Health Institute (IHI) and the National Institute for ...

Fondazione Telethon ETS' Waskyra has become the first gene therapy in the US for patients with Wiskott-Aldrich syndrome (WAS) ...

Biologists poured cold water on Colossal Biosciences’ claim to have brought the dire wolf back from extinction, and some ...

The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the ...

The "Plant Breeding and CRISPR Plants - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Plant Breeding and CRISPR Plants was valued at US$21 ...

India’s seed diversity faces rising corporate capture and GE risks; farmers fight for sovereignty and agroecology. Explore what’s at stake and why it matters.

The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel), the first cell-based gene therapy for ...

A new study shows that disrupted brain lipids play a central role in Alzheimer’s disease. Researchers found that microglia ...

The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel), the first cell-based gene therapy for the treatment of a rare, genetic immune disorder ...

These trends threaten to undermine progress made in tackling animal vector-borne pathogens, including decades of investment and emerging technologies such as harnessing bacteria, genetic engineering ...

It's long been thought that age is the most significant risk factor for cancer since, over time, genetic mutations accumulate in cells, and this gradual buildup can eventually lead to cancer ...